PTAB Axes RapidPulse Blood Clot Removal Patent
Law360Law360
The most comprehensive patent reform in over sixty years was brought about by the Leahy-Smith America Invents Act (“AIA”), which includes a complete restructuring of the post-grant patent proceedings at the U.S. Patent & Trademark Office (“USPTO”).
Included in these reforms are the new post-grant procedures intended to provide a faster, more affordable alternative to traditional patent litigation in federal district court. Not only do these procedures have statutory time limits for completion, usually within one year of institution of a proceeding, but they impose significant restrictions on the breadth of discovery available to parties in order to facilitate compliance with the statutory time limits. Given the expedited timelines and significant differences from traditional patent litigation, to take advantage of these new processes for challenging patents, practitioners must possess a thorough understanding of the complexity of the AIA as well as how the Patent Trial and Appeal Board (“PTAB”) the entity charged with handling these proceedings, is interpreting the Act.
Our patent lawyers’ knowledge of patent prosecution, familiarity with the operations of the USPTO, and our courtroom skills differentiate us from competitors. Baker Botts lawyers have handled more than 600 proceedings before the PTAB. This combination of skills and experience makes our lawyers the natural choice for clients looking to pursue this new patent prosecution avenue.
Baker Botts maintains a team of accomplished and experienced professionals dedicated to understanding all aspects of the post-grant proceedings and are constantly monitoring all aspects of the AIA, including the various orders and decisions being issued by the PTAB on a near-daily basis. This team issues its Post-Grant Report on a regular basis commenting on key aspects of the AIA and provides context to important PTAB decisions.
In addition, Baker Botts IP lawyers are already recognized as skilled practitioners in the field. We were involved in the rulemaking regarding the creation of the PTAB following passage of the AIA, including post-grant review, inter partes review, and covered business method review.
On August 14, 2012, the USPTO published final rules in the Federal Register to implement various Sections of the AIA, which became effective on September 16, 2012.
These rules address the following:
Law360
Law360
Law360
Law360
Law360
Foss Patents
Law360
New York Law Journal
bloomberglaw.com
Law360
bloomberglaw.com
Law360
Managing IP
law360.com
law360.com
Law.com
Law360
Law360
Law360
Law360
Law360
Bloomberg Law
Law360
Bloomberg Law
Law360
Law.com
Bloomberg Law
Law360
Law360
New York Law Journal
National Law Journal, The
Washington Legal Foundation
Law360
Law360
Bloomberg Law
Law360
Law360
Law360
Law360
Daily Journal
Law360
Law.com
Global Legal Chronicle
Law.com
Bloomberg Law
Law360
Law360
Law360
Law360
Law360
Law360
Law360
Law360
Law360
Law360
Law360
Law360
National Law Journal, The
Law360
Future Science OA
Law360
Law360
Law360
Law360
Law360
Recorder, The
Law360
Law360
Law360
Intellectual Property & Technology Law Journal
Intellectual Property Report
Intellectual Property Update
Intellectual Property Update
Intellectual Property Update
Intellectual Property Update
Intellectual Property Update
IP Update
New York Law Journal, Volume 268, No. 100
New York Law Journal, Volume 268, No. 62
New York Law Journal, Volume 268, No. 20
New York Law Journal, Volume 267 - NO. 100
New York Law Journal, Volume 267, No. 55
Intellectual Property Update
Intellectual Property Report
BCLT's Expert Series Podcast
New York Law Journal, Volume 266, No. 20
New York Law Journal
New York Law Journal, Volume 265, No. 55.
Intellectual Property Report
New York Law Journal, Volume 264, No. 102
AIPLA PTAB Committee
Future Science OA, Pharmaceutical Patent Analyst, Vol. 8, No. 3
The 2020 Virtual PTAB Bench + Bar program will take place on August 20th, 2020.
Partner Eliot Williams will be speaking on an Intellectual Property Owners Association (IPO) webinar covering the substantial and fast-moving legal activity already unleashed by the Arthrex decision.